Cargando…

PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2

BACKGROUND: Anti-neutrophil cytoplasmic antibodies (ANCA) is autoantibodies characteristic of vasculitis diseases. A connection between ANCA and Wegener's granulomatosis was well established. The interaction of both ANCA phenotypes (PR3-ANCA and MPO-ANCA) with leukocytes provoked cell activatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Uehara, Akiko, Sato, Tadasu, Iwashiro, Atsushi, Yokota, Sou
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717921/
https://www.ncbi.nlm.nih.gov/pubmed/19594951
http://dx.doi.org/10.1186/1746-1596-4-23
_version_ 1782169930999791616
author Uehara, Akiko
Sato, Tadasu
Iwashiro, Atsushi
Yokota, Sou
author_facet Uehara, Akiko
Sato, Tadasu
Iwashiro, Atsushi
Yokota, Sou
author_sort Uehara, Akiko
collection PubMed
description BACKGROUND: Anti-neutrophil cytoplasmic antibodies (ANCA) is autoantibodies characteristic of vasculitis diseases. A connection between ANCA and Wegener's granulomatosis was well established. The interaction of both ANCA phenotypes (PR3-ANCA and MPO-ANCA) with leukocytes provoked cell activation, which might be involved in the pathogenesis of ANCA-related Wegener's granulomatosis. METHODS: In this study, we examined whether PR3-ANCA sera and purified immunoglobulins from patients with Wegener's granulomatosis prime human monocytic cells for enhanced responses to microbial components in terms of production of proinflammatory cytokines. RESULTS: Flow cytometry demonstrated that stimulation with antibodies to proteinase 3 enhanced the expression of TLR2, 3, 4, 7, and 9, NOD1, and NOD2 in human mononuclear cells. The sera and purified immunoglobulins significantly primed human mononuclear cells to secrete interleukin-8 in response to microbial components via TLRs and NODs. Priming effects were also observed for the production of interleukin-6, monocyte chemoattractant protein-1, and tumor necrosis factor-α. On the other hand, PR3-ANCA-negative sera from patients with polyarteritis nodosa which possibly related to MPO-ANCA and aortitis syndrome as well as control sera from a healthy volunteer did not have any priming effects on PBMCs. CONCLUSION: In conclusion, PR3-ANCA prime human mononuclear cells to produce cytokines upon stimulation with various microbial components by up-regulating the TLR and NOD signaling pathway, and these mechanisms may partially participate in the inflammatory process in Wegener's granulomatosis.
format Text
id pubmed-2717921
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27179212009-07-30 PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2 Uehara, Akiko Sato, Tadasu Iwashiro, Atsushi Yokota, Sou Diagn Pathol Research BACKGROUND: Anti-neutrophil cytoplasmic antibodies (ANCA) is autoantibodies characteristic of vasculitis diseases. A connection between ANCA and Wegener's granulomatosis was well established. The interaction of both ANCA phenotypes (PR3-ANCA and MPO-ANCA) with leukocytes provoked cell activation, which might be involved in the pathogenesis of ANCA-related Wegener's granulomatosis. METHODS: In this study, we examined whether PR3-ANCA sera and purified immunoglobulins from patients with Wegener's granulomatosis prime human monocytic cells for enhanced responses to microbial components in terms of production of proinflammatory cytokines. RESULTS: Flow cytometry demonstrated that stimulation with antibodies to proteinase 3 enhanced the expression of TLR2, 3, 4, 7, and 9, NOD1, and NOD2 in human mononuclear cells. The sera and purified immunoglobulins significantly primed human mononuclear cells to secrete interleukin-8 in response to microbial components via TLRs and NODs. Priming effects were also observed for the production of interleukin-6, monocyte chemoattractant protein-1, and tumor necrosis factor-α. On the other hand, PR3-ANCA-negative sera from patients with polyarteritis nodosa which possibly related to MPO-ANCA and aortitis syndrome as well as control sera from a healthy volunteer did not have any priming effects on PBMCs. CONCLUSION: In conclusion, PR3-ANCA prime human mononuclear cells to produce cytokines upon stimulation with various microbial components by up-regulating the TLR and NOD signaling pathway, and these mechanisms may partially participate in the inflammatory process in Wegener's granulomatosis. BioMed Central 2009-07-14 /pmc/articles/PMC2717921/ /pubmed/19594951 http://dx.doi.org/10.1186/1746-1596-4-23 Text en Copyright © 2009 Uehara et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Uehara, Akiko
Sato, Tadasu
Iwashiro, Atsushi
Yokota, Sou
PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2
title PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2
title_full PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2
title_fullStr PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2
title_full_unstemmed PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2
title_short PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2
title_sort pr3-anca in wegener's granulomatosis prime human mononuclear cells for enhanced activation via tlrs and nod1/2
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717921/
https://www.ncbi.nlm.nih.gov/pubmed/19594951
http://dx.doi.org/10.1186/1746-1596-4-23
work_keys_str_mv AT ueharaakiko pr3ancainwegenersgranulomatosisprimehumanmononuclearcellsforenhancedactivationviatlrsandnod12
AT satotadasu pr3ancainwegenersgranulomatosisprimehumanmononuclearcellsforenhancedactivationviatlrsandnod12
AT iwashiroatsushi pr3ancainwegenersgranulomatosisprimehumanmononuclearcellsforenhancedactivationviatlrsandnod12
AT yokotasou pr3ancainwegenersgranulomatosisprimehumanmononuclearcellsforenhancedactivationviatlrsandnod12